Safety data sheet
Standardized safety protocols and material specifications for professional use.
Certificate of Analysis
Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-lemonbottle-10mg
Lemonbottle (10mg)
Research Grade >99% Purity
Authorized Resellers
Available through our trusted partners
123peptide.com
Netherlands · Europe
local_shipping2-3 Business Days
Depeptidenwinkel.com
Netherlands · Europe
local_shipping2-3 Business Days
Scientific Background
Lemonbottle is a premium lipolytic solution combining three bioactive components: Riboflavin (Vitamin B2), Lecithin (phosphatidylcholine), and Bromelain — each selected for complementary mechanisms in adipocyte disruption and fat metabolism.
Riboflavin (CAS 83-88-5) acts as a photosensitiser and metabolic co-factor, enhancing cellular energy metabolism and supporting lipid oxidation pathways. Lecithin (CAS 8002-43-5), rich in phosphatidylcholine, disrupts adipocyte membranes and facilitates the emulsification and clearance of released fatty acids via the lymphatic system. Bromelain (CAS 9001-00-7), a pineapple-derived proteolytic enzyme, reduces localised inflammation and oedema, supporting post-treatment recovery and lymphatic drainage.
Together, these compounds are studied for their role in localised lipolysis, particularly in subcutaneous adipose tissue research, contouring applications, and fat-redistribution models.
Intended Research Use
- Localised subcutaneous lipolysis research
- Adipocyte membrane disruption (phosphatidylcholine mechanism)
- Lymphatic fat clearance studies
- Localised inflammation and oedema reduction post-lipolysis
- Body contouring and fat redistribution models
- Riboflavin-mediated metabolic enhancement studies
menu_bookScientific Publications
Journal of Cosmetic Dermatology (2018)
Phosphatidylcholine injection for non-surgical fat reduction: mechanisms and clinical outcomes
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/29989331/
Aesthetic Surgery Journal (2020)
Bromelain reduces post-procedure oedema and inflammation in lipolytic treatment models
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/31560041/
FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.
Possible stacks with other peptides
Synergistic combinations for enhanced research outcomes
Lemonbottle is often combined with complementary peptides and compounds to support broader body composition and anti-inflammatory research protocols.
Lipo-C (120mg vial)
arrow_forwardmyo-lipo-c-120mg
Complementary lipotropic support — Lipo-C's MIC + L-Carnitine blend provides systemic lipid metabolism support alongside Lemonbottle's localised lipolytic action.
AICAR (50mg vial)
arrow_forwardmyo-aicar-50mg
Metabolic synergy — AICAR activates AMPK and enhances fatty acid oxidation, complementing the fat mobilisation initiated by Lemonbottle.
GHK-Cu 50mg (50mg vial)
arrow_forwardmyo-ghk-cu-50mg
Skin integrity support — GHK-Cu promotes collagen synthesis and skin elasticity, counteracting any skin laxity in the treated area during lipolysis research.
KPV (10mg vial)
arrow_forwardmyo-kpv-10mg
Anti-inflammatory adjunct — KPV suppresses cytokine-driven inflammation at injection sites, potentially reducing oedema duration and improving recovery between sessions.
Cycling Note: Sessions are not cycled in the traditional sense — protocols run 3–6 sessions spaced 7–14 days apart, then a rest period of 4–8 weeks before re-evaluation.